Trial Profile
Topical Treatment of Bacterial Conjunctivitis and Its Effect on Microbial Flora.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Jun 2012
Price :
$35
*
At a glance
- Drugs Moxifloxacin (Primary)
- Indications Bacterial infections; Infectious conjunctivitis
- Focus Pharmacodynamics
- Sponsors Alcon
- 01 Jun 2012 Actual end date Jun 2007 added as reported by ClinicalTrials.gov.
- 09 Feb 2010 Actual patient number (137) added as reported by ClinicalTrials.gov.
- 09 Feb 2010 Investigational drug changed from trimethoprim/polymixin B to moxifloxacin as reported by ClinicalTrials.gov.